Please Enable JavaScript

www.laserfocusworld.comis using a security service for protection against online attacks.
The service requires full JavaScript support in order to view this website.

Please enable JavaScript on your browser and try again.

www.laserfocusworld.com is using a security service for protection against online attacks. This process is automatic. You will be redirected once the validation process is complete.

Roche Holding Ltd (OP: RHHBF )

280.85 -3.85 (-1.35%)

Streaming Delayed Price Updated: 9:30 AM EST, Dec 23, 2024 Add to My Watchlist

Price and Volume

Volume	150
Open	310.14
Bid (Size)	N/A (0)
Ask (Size)	N/A (0)
Prev. Close	284.70
Today's Range	280.85 - 310.14
52wk Range	243.42 - 368.43
Shares Outstanding	N/A
Dividend Yield	N/A

Chart for (: )

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

Novartis To Axe 680 Development Jobs Amid Global Reshuffle: Report

April 09, 2024

Novartis reportedly plans to cut 680 development jobs worldwide, separate from an 8,000-employee restructuring, aiming to reshape its workforce and tap local talent pools.

Roche Agrees To Purchase Part Of COVID-19 Test Player LumiraDx Diagnostics Platform For $295M

January 02, 2024

Friday, LumiraDx Limited (NASDAQ: LMDX) appointed joint administrators for two subsidiaries.

Performance

YTD	-8.56%	-8.56%
1 Month	-2.56%	-2.56%
3 Month	-21.35%	-21.35%
6 Month	-11.68%	-11.68%
1 Year	-12.41%	-12.41%

More News

Poseida Therapeutics' New Treatment For Multiple Myeloma Shows Early Success In Clinical Trial

December 11, 2023

Roche's Combination Therapy Shows Improved Progression Free Survival In Certain Breast Cancer With Mutation

December 05, 2023

Roche Joins Bandwagon To Challenge Novo Nordisk, Eli Lilly For Weight Loss Drugs

December 04, 2023

Sarepta/Roche's Closely Watched Duchenne Gene Therapy Faces More FDA Scrutiny - Stock Tanks

October 31, 2023

Roche Buys Pfizer & Roivant Sciences' Televant In ~$7.1B Deal

October 23, 2023

Roche Reports Nine Months Sales Growth Despite Lower Sales From COVID-19 Products

October 19, 2023

What's Going On Cancer Player Monte Rosa Therapeutics Stock Today?

October 17, 2023

Is There A Blood Test for Alzheimer's? Progress Underway, But Not Quite Ready

October 11, 2023

Cancer Drug Maker 3D Medicines Inc. Trading Higher After Company Announces It Will Repurchase Up To 10% Of Outstanding Shares

October 04, 2023

Ionis-Roche Join Forces To Compete In Neurodegenerative Disease Space, Analyst Sees Short-Term Challenges

September 27, 2023

Biden Administration Restarts Distribution Of Free At Home COVID-19 Tests, After Suspending For Year

September 21, 2023

Hypertension Impacts 1.2B People - Alnylam's Gene Silencing Drug Candidate Hits the Mark in Phase 2 Study, Offering Hope

September 07, 2023

Roche's Approved Lung Cancer Drug Beats Chemo In Rare Type Of Lung Cancer

September 01, 2023

Cancer Treatment In 7 Minutes: UK's Health Service To Rollout Roche's Tencentriq Injection Cutting Treatment Time

August 30, 2023

Who Are Other Players Gaining From Roche's Accidental Lung Cancer Data Update

August 23, 2023

Roche's Accidental Lung Cancer Trial Data Leak: Shows Encouraging Early Data From Combination Therapy Study

August 23, 2023

Third Time Lucky: Exelixis' Cabozantinib Combo Therapy Aces Pivotal Study In Prostate Cancer Patients

August 21, 2023

Johnson & Johnson, Other Pharma Makers Anticipate Reformulated Injectable Drugs May Exclude Price Negotiations

July 28, 2023

Novo Nordisk's Obesity Drug Saxenda Not Included In WHO's Essential Drug List

July 26, 2023

Alnylam Inks Co-Development, Co-Commercialization Pact With Roche For Hypertension Therapy

July 24, 2023

Republican Presidential Candidate Vivek Ramaswamy Founded Roivant In Discussions With Roche For $7B Stomach Disease(s) Drug Deal

July 14, 2023

Roche's Approved Multiple Sclerosis Drug: Subcutaneous Injection At Par With Intravenous Infusion

July 13, 2023

Roche's Bispecific Antibody With Fixed-Duration Treatment Scores FDA Approval For Type Of Lymphoma

June 16, 2023

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.